Open, randomized, multi-center phase II study comparing efficacy and tolerability of Erlotinib vs. Carboplatin/Vinorelbin in elderly patients (>70 years of age) with untreated non-small cell lung cancer. (Q54375713)
Jump to navigation
Jump to search
scientific article published on 3 February 2014
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Open, randomized, multi-center phase II study comparing efficacy and tolerability of Erlotinib vs. Carboplatin/Vinorelbin in elderly patients (>70 years of age) with untreated non-small cell lung cancer. |
scientific article published on 3 February 2014 |
Statements
Open, randomized, multi-center phase II study comparing efficacy and tolerability of Erlotinib vs. Carboplatin/Vinorelbin in elderly patients (>70 years of age) with untreated non-small cell lung cancer. (English)
D F Heigener
K M Deppermann
J V Pawel
J R Fischer
C Kortsik
S Bohnet
M V Eiff
W Koester
M Thomas
P A Schnabel
M Reck
3 February 2014
84
1
62-66